Sophia Genetics SA (NASDAQ:SOPH) is set to release its Q4 2024 earnings on March 4, 2025. The consensus estimate for Q4 2024 revenue is $17.72 million, and the earnings are expected to come in at ...
SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback